新研究发现copidogrel比CAD病人的阿司匹林更能减少重大心脏病事件。 New study finds clopidogrel reduces major heart events more than aspirin in CAD patients.

一项新的研究表明,血液稀释剂(copidogrel)在预防心脏病、中风和冠状动脉疾病(CAD)患者死亡方面比阿司匹林更有效。 A new study suggests that clopidogrel, a blood thinner, is more effective than aspirin in preventing heart attacks, strokes, and death in patients with coronary artery disease (CAD). 研究人员分析了近29,000名患者,发现与阿司匹林相比,使用皮多格雷尔的患者患重大不良事件的风险降低了14%,严重出血的发生率也相似. Analyzing nearly 29,000 patients, researchers found that those on clopidogrel had a 14% lower risk of major adverse events compared to those on aspirin, with similar rates of major bleeding. 这挑战了目前治疗CAD时对阿司匹林的偏好。 This challenges the current preference for aspirin in treating CAD.